• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

参加两项羟丁酸钠临床试验的发作性睡病患者中,Epworth嗜睡量表与清醒维持试验之间的相关性。

Correlation between the Epworth Sleepiness Scale and the Maintenance of Wakefulness Test in patients with narcolepsy participating in two clinical trials of sodium oxybate.

作者信息

Erman Milton, Emsellem Helene, Black Jed, Mori Fannie, Mayer Geert

机构信息

Pacific Sleep Medicine, Oceanside, CA, USA.

The Center for Sleep & Wake Disorders, Chevy Chase, MD, USA.

出版信息

Sleep Med. 2017 Oct;38:92-95. doi: 10.1016/j.sleep.2017.07.015. Epub 2017 Aug 2.

DOI:10.1016/j.sleep.2017.07.015
PMID:29031763
Abstract

BACKGROUND

In evaluating pathologic sleepiness, the Epworth Sleepiness Scale (ESS) assesses subjective sleep propensity; the Maintenance of Wakefulness Test (MWT) is an objective measure of the ability to stay awake. This analysis evaluated the strength of the correlation between ESS and MWT with regard to absolute values in scores.

METHODS

Data were analyzed separately from the intent-to-treat populations of two eight-week clinical trials of sodium oxybate for the treatment of narcolepsy, SXB-15 and SXB-22. For all treatment groups, correlations between ESS and MWT were evaluated at baseline, week four, and week eight using the Pearson product-moment correlation coefficient.

RESULTS

Overall, correlations across all treatment groups in each study described an inverse relationship, reflecting the scoring of each measure (ie, whereas higher ESS scores indicate greater sleepiness, higher MWT scores indicate a greater ability to remain awake). Significant correlations of low-to-moderate strength were observed at all time points in both studies. In SXB-15, correlation coefficients were -0.272, -0.365, and -0.343 at baseline (n = 221), week four (n = 212), and week eight (n = 205), respectively, with all P < 0.0001. Similarly, in SXB-22, correlation coefficients were -0.302 (n = 216), -0.418 (n = 211), and -0.432 (n = 196) at the three time points, respectively, also with all P < 0.0001.

CONCLUSION

Although all correlations showed statistical significance, they were of low-to-moderate strength. These results indicate that ESS and MWT measure features of pathologic sleepiness that may be distinct, but partially overlapping. These data corroborate those of other studies, suggesting that physiologic mechanisms that regulate alertness and sleep propensity may function somewhat independently.

摘要

背景

在评估病理性嗜睡时,爱泼沃斯嗜睡量表(ESS)评估主观睡眠倾向;清醒维持试验(MWT)是对保持清醒能力的客观测量。本分析评估了ESS与MWT在分数绝对值方面的相关性强度。

方法

数据分别来自两项为期八周的治疗发作性睡病的羟丁酸钠临床试验(SXB - 15和SXB - 22)的意向性治疗人群。对于所有治疗组,使用Pearson积矩相关系数在基线、第4周和第8周评估ESS与MWT之间的相关性。

结果

总体而言,每项研究中所有治疗组的相关性均呈现负相关关系,反映了每种测量方法的评分情况(即,ESS得分越高表明嗜睡程度越高,而MWT得分越高表明保持清醒的能力越强)。两项研究在所有时间点均观察到低至中等强度的显著相关性。在SXB - 15中,基线时(n = 221)、第4周时(n = 212)和第8周时(n = 205)的相关系数分别为 - 0.272、 - 0.365和 - 0.343,所有P值均<0.0001。同样,在SXB - 22中,三个时间点的相关系数分别为 - 0.302(n = 216)、 - 0.418(n = 211)和 - 0.432(n = 196),所有P值也均<0.0001。

结论

虽然所有相关性均具有统计学意义,但强度为低至中等。这些结果表明,ESS和MWT测量的病理性嗜睡特征可能不同,但部分重叠。这些数据证实了其他研究的结果,表明调节警觉性和睡眠倾向的生理机制可能在一定程度上独立发挥作用。

相似文献

1
Correlation between the Epworth Sleepiness Scale and the Maintenance of Wakefulness Test in patients with narcolepsy participating in two clinical trials of sodium oxybate.参加两项羟丁酸钠临床试验的发作性睡病患者中,Epworth嗜睡量表与清醒维持试验之间的相关性。
Sleep Med. 2017 Oct;38:92-95. doi: 10.1016/j.sleep.2017.07.015. Epub 2017 Aug 2.
2
Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy.羟丁酸钠、莫达非尼及联合治疗对伴或不伴猝倒发作的发作性睡病患者日间过度嗜睡的影响
Sleep Med. 2016 Aug;24:57-62. doi: 10.1016/j.sleep.2016.07.010. Epub 2016 Aug 22.
3
Efficacy of once-nightly sodium oxybate (FT218) in narcolepsy type 1 and type 2: post hoc analysis from the Phase 3 REST-ON Trial.苯海拉明(FT218)每晚一次治疗 1 型和 2 型发作性睡病的疗效:来自 3 期 REST-ON 试验的事后分析。
Sleep. 2023 Nov 8;46(11). doi: 10.1093/sleep/zsad152.
4
Sodium oxybate improves excessive daytime sleepiness in narcolepsy.羟丁酸钠可改善发作性睡病患者的日间过度嗜睡症状。
Sleep. 2006 Jul;29(7):939-46. doi: 10.1093/sleep/29.7.939.
5
Effect of Oral JZP-110 (ADX-N05) on Wakefulness and Sleepiness in Adults with Narcolepsy: A Phase 2b Study.口服JZP-110(ADX-N05)对发作性睡病成人清醒和嗜睡的影响:一项2b期研究。
Sleep. 2016 Jul 1;39(7):1379-87. doi: 10.5665/sleep.5968.
6
Findings of the Maintenance of Wakefulness Test and its relationship with response to modafinil therapy for residual excessive daytime sleepiness in obstructive sleep apnea patients adequately treated with nasal continuous positive airway pressure.阻塞性睡眠呼吸暂停患者经鼻持续气道正压通气充分治疗后,清醒维持测试的结果及其与莫达非尼治疗残余日间过度嗜睡反应的关系。
Sleep Med. 2016 Nov-Dec;27-28:45-48. doi: 10.1016/j.sleep.2016.06.035. Epub 2016 Oct 27.
7
Validation of the Epworth Sleepiness Scale for Children and Adolescents (ESS-CHAD) questionnaire in pediatric patients with narcolepsy with cataplexy aged 7-16 years.验证儿童和青少年嗜睡量表(ESS-CHAD)问卷在 7-16 岁发作性睡病伴猝倒症的儿科患者中的适用性。
Sleep Med. 2022 Jan;89:78-84. doi: 10.1016/j.sleep.2021.11.003. Epub 2021 Nov 11.
8
Criteria for gauging response to sodium oxybate for narcolepsy.评估钠缬草酸盐治疗发作性睡病反应的标准。
J Sleep Res. 2018 Aug;27(4):e12628. doi: 10.1111/jsr.12628. Epub 2017 Dec 5.
9
Evaluation of the effect of JZP-110 in patients with narcolepsy assessed using the Maintenance of Wakefulness Test censored to 20 minutes.使用截尾至20分钟的清醒维持测试评估JZP - 110对发作性睡病患者的疗效。
Sleep Med. 2017 Jul;35:12-16. doi: 10.1016/j.sleep.2017.03.025. Epub 2017 Apr 22.
10
Subjective sleepiness ratings (Epworth sleepiness scale) do not reflect the same parameter of sleepiness as objective sleepiness (maintenance of wakefulness test) in patients with narcolepsy.在发作性睡病患者中,主观嗜睡评分(爱泼沃斯嗜睡量表)所反映的嗜睡参数与客观嗜睡(清醒度维持测试)并不相同。
Clin Neurophysiol. 1999 Dec;110(12):2131-5. doi: 10.1016/s1388-2457(99)00167-4.

引用本文的文献

1
Evaluation of psychometric properties of patient-reported outcome measures frequently used in narcolepsy randomized controlled trials: a systematic review.评估常用于发作性睡病随机对照试验的患者报告结局测量工具的心理计量学特性:系统评价。
Sleep. 2022 Oct 10;45(10). doi: 10.1093/sleep/zsac156.
2
Fatigue, sleepiness and depression in multiple sclerosis: defining the overlaps for a better phenotyping.多发性硬化症中的疲劳、嗜睡和抑郁:定义重叠以进行更好的表型分析。
J Neurol. 2022 Sep;269(9):4961-4971. doi: 10.1007/s00415-022-11143-6. Epub 2022 May 4.
3
Sleep-Related Breathing Disorders in Multiple Sclerosis: Prevalence, Features and Associated Factors.
多发性硬化症中与睡眠相关的呼吸障碍:患病率、特征及相关因素
Nat Sci Sleep. 2022 Apr 20;14:741-750. doi: 10.2147/NSS.S359858. eCollection 2022.
4
Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof-of-Concept Trial.索里昂氨酯治疗帕金森病日间过度嗜睡的疗效:Ⅱ期概念验证试验。
Mov Disord. 2021 Oct;36(10):2408-2412. doi: 10.1002/mds.28702. Epub 2021 Jun 30.
5
Excessive Daytime Sleepiness in Obstructive Sleep Apnea. Mechanisms and Clinical Management.阻塞性睡眠呼吸暂停中过度日间嗜睡。发病机制与临床管理。
Ann Am Thorac Soc. 2021 May;18(5):757-768. doi: 10.1513/AnnalsATS.202006-696FR.
6
A Case of Off-label Sodium Oxybate in an 11-Year-Old with Narcolepsy.一例11岁发作性睡病患者使用羟丁酸钠超说明书用药的病例
Cureus. 2019 Feb 12;11(2):e4057. doi: 10.7759/cureus.4057.
7
Assessing readiness to drive in adolescents with narcolepsy: what are providers doing?评估青少年发作性睡病患者的驾驶能力:提供者在做什么?
Sleep Breath. 2019 Jun;23(2):611-617. doi: 10.1007/s11325-019-01799-2. Epub 2019 Feb 8.
8
A randomized study of solriamfetol for excessive sleepiness in narcolepsy.一项关于索里昂(solriamfetol)治疗发作性睡病过度嗜睡的随机研究。
Ann Neurol. 2019 Mar;85(3):359-370. doi: 10.1002/ana.25423.